首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1634155

全球体外受精 (IVF) 服务市场 - 2025 - 2032

Global In Vitro Fertilization (IVF) Services Market - 2025 - 2032

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球体外受精（IVF）服务市场规模达249.1亿美元，预计2032年将达到480.4亿美元，2025-2032年预测期间复合年增长率为8.6%。

体外受精 (IVF) 服务是一种透过在体外（通常在实验室环境中）将卵子与精子结合来促进受精的医疗程序。 “体外”一词翻译为“在玻璃中”，表示受精过程发生在受控环境中，而不是在人体内。 IVF过程通常由几个关键步骤组成，包括卵巢刺激、取卵、受精、胚胎培养和胚胎移植。

体外受精服务通常用于解决各种不孕原因，包括高龄产妇、输卵管阻塞、男性因素不孕、子宫内膜异位症和不明原因不孕。对于许多面临与生育相关的挑战而寻求怀孕的夫妇来说，该手术已成为一个重要的选择。这些因素扩大了全球体外受精（IVF）服务市场。

市场动态：

驱动程式和限制

不孕症发生率增加

不孕症发生率的增加极大地推动了全球体外受精（IVF）服务市场的成长，预计这种成长将在整个市场预测期内持续下去。

不孕症发生率的上升是推动全球体外受精（IVF）服务市场成长的关键因素。不孕率的增加可能与近几十年来出现的一系列社会、经济和健康相关因素有关。

根据 2024 年 10 月的 Cofertility资料，不孕症是一个重大的全球健康问题，影响着全球约六分之一的人。这项统计数据凸显了不孕症的普遍存在是一个超越地理和社会经济界线的主要问题。大约 17.5% 的成年人在一生中的某个阶段经历过不孕不育。

这相当于大约六分之一的人，显示不孕不育是影响全球数百万人的普遍问题。大约 12% 的女性在怀孕或生孩子方面遇到困难。 19% 的夫妇在无保护性交一年后无法怀孕。此外，10% 的夫妇在无保护性行为两年后仍然无法怀孕，这表明长期不孕是许多人的常见经历。

不孕症发病率的增加与体外受精服务的需求增加有直接关係。随着越来越多的夫妇寻求受孕协助，生育诊所的患者数量不断增加，服务范围也不断扩大。辅助生殖技术的利用以每年 5% 至 10% 的速度成长，反映出人们越来越依赖 IVF 作为不孕症的可行解决方案。生殖技术的进步进一步推动了这一趋势，提高了成功率并使治疗更有效。

此外，产业技术进步和创新发布的关键参与者将推动体外受精 (IVF) 服务市场的成长。例如，2023年9月，德国达姆施塔特默克公司启动了生育福利计划，旨在为接受生育治疗的员工提供财务支持。这项措施反映了公司致力于提高员工福祉并解决与不孕症相关的情感和经济负担。

此外，2023 年 9 月，生殖科技公司 AIVF 在巴西戈亚尼亚的 Perfetto 诊所推出了首个人工智慧驱动的 IVF 作业系统。这项重大扩张是为了满足全球对体外受精治疗日益增长的需求，旨在提高生育护理的效率和效果。所有这些因素都需要全球体外受精（IVF）服务市场。

此外，对采用先进技术的需求不断增长，有助于全球体外受精（IVF）服务市场的扩张。

体外受精程序的高成本

体外受精程序的高成本将阻碍全球体外受精（IVF）服务市场的成长。全球体外受精 (IVF) 服务市场受到阻碍其成长和可及性的各种限制的严重影响。其中，高昂的治疗费用、经济负担和伦理考量是最重要的。

根据 2022 年 10 月的 Fierce Healthcare 新闻，与不孕症治疗（尤其是体外受精 (IVF)）相关的财务负担是巨大的。在美国，一个 IVF 週期的费用通常约为 12,000 美元，但如果考虑到药物和其他手术，这个数字可能会上升到 25,000 美元。鑑于许多患者在第一次尝试时未能怀孕，他们通常会接受平均三到五个週期的多个週期，以增加成功的机会。

许多患者发现他们需要多个 IVF 週期才能成功怀孕。研究表明，每位患者平均接受约 2.3 至 2.7 个週期，随着时间的推移，累积费用可能超过 50,000 美元。每个额外周期的平均费用约为 6,955 美元，进一步加剧了夫妇的经济压力5。在生育治疗保险覆盖范围有限或不存在的地区，这种情况尤其具有挑战性。由于缺乏涵盖体外受精治疗的综合保险政策，许多夫妇面临巨额自付费用。试管婴儿的费用根据地理位置的不同可能会大不相同。例如，与农村地区的诊所相比，主要大都市地区的诊所收取的费用可能更高。

因此，上述因素可能限制全球体外受精（IVF）服务市场的潜在成长。

In Vitro Fertilization (IVF) services is a medical procedure that facilitates fertilization by combining an egg with sperm outside the body, typically in a laboratory environment. The term "in vitro," which translates to "in glass," signifies that the fertilization process occurs in a controlled setting rather than within the human body. The IVF process generally consists of several key steps including ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer.

IVF services are commonly employed to address various causes of infertility, including advanced maternal age, blocked fallopian tubes, male factor infertility, endometriosis, and unexplained infertility. This procedure has become a vital option for many couples seeking to conceive when faced with challenges related to fertility. These factors have expanded the global in vitro fertilization (IVF) services market.

Market Dynamics: Drivers & Restraints

Increasing Incidence of Infertility

The increasing incidence of infertility is significantly driving the growth of the global in vitro fertilization (IVF) services market, which is expected to continue throughout the market forecast period.

The rising incidence of infertility is a key factor driving the growth of the global in vitro fertilization (IVF) services market. This increase in infertility rates can be linked to a range of social, economic, and health-related factors that have developed over recent decades.

As per the Cofertility data in October 2024, infertility is a significant global health issue, affecting approximately 1 in 6 individuals worldwide. This statistic highlights the prevalence of infertility as a major concern that transcends geographical and socioeconomic boundaries. About 17.5% of the adult population experiences infertility at some point in their lives.

This translates to roughly 1 in 6 individuals, indicating that infertility is a widespread issue affecting millions globally. Approximately 12% of women encounter difficulties either becoming pregnant or carrying a child to term. 19% of all couples are unable to conceive after one year of unprotected sexual intercourse. Furthermore, 10% of couples remain unable to conceive after two years of unprotected sex, indicating that prolonged infertility is a common experience for many.

The increasing incidence of infertility is directly linked to a heightened demand for IVF services. As more couples seek assistance in conceiving, fertility clinics are experiencing a rise in patient volumes and expanding their range of service offerings. The utilization of assisted reproductive technologies has been growing at an annual rate of 5% to 10%, reflecting a growing reliance on IVF as a viable solution for infertility. This trend is further bolstered by advancements in reproductive technology that enhance success rates and make treatments more effective.

Furthermore, key players in the industry technological advancements, and innovative launches that would drive this in vitro fertilization (IVF) services market growth. For instance, in September 2023, Merck KGaA, Darmstadt, Germany, launched a Fertility Benefits Program aimed at providing financial support for employees undergoing fertility treatments. This initiative reflects the company's commitment to enhancing employee well-being and addressing the emotional and financial burdens associated with infertility.

Also, in September 2023, AIVF, a reproductive technology company, launched the first AI-powered IVF operating system at the Perfetto Clinic in Goiania, Brazil. This significant expansion comes in response to the increasing global demand for IVF treatments and aims to enhance the efficiency and effectiveness of fertility care. All these factors demand the global in vitro fertilization (IVF) services market.

Moreover, the rising demand for the adoption of advanced technologies contributes to the global in vitro fertilization (IVF) services market expansion.

High Costs of IVF Procedures

The high costs of IVF procedures will hinder the growth of the global in vitro fertilization (IVF) services market. The global in vitro fertilization (IVF) services market is significantly impacted by various restraints that hinder its growth and accessibility. Among these, high treatment costs, financial burdens, and ethical considerations are paramount.

As per Fierce Healthcare news in October 2022, the financial burden associated with infertility treatments, particularly In Vitro Fertilization (IVF), is substantial. In the U.S., a single IVF cycle typically costs around $12,000, but this figure can escalate to $25,000 when factoring in medications and additional procedures. Given that many patients do not achieve pregnancy on their first attempt, they often undergo multiple cycles averaging between three to five cycles to increase their chances of success.

Many patients find that they require multiple IVF cycles to achieve a successful pregnancy. Research indicates that the average patient undergoes approximately 2.3 to 2.7 cycles, leading to cumulative expenses that can exceed $50,000 over time. Each additional cycle incurs an average cost of around $6,955, further compounding the financial strain on couples5. This situation is particularly challenging in regions where insurance coverage for fertility treatments is limited or nonexistent. Many couples face significant out-of-pocket expenses due to the lack of comprehensive insurance policies that cover IVF treatments. The cost of IVF can vary significantly based on geographic location. For instance, clinics in major metropolitan areas may charge higher rates compared to those in rural settings.

Thus, the above factors could be limiting the global in vitro fertilization (IVF) services market's potential growth.

Segment Analysis

The global in vitro fertilization (IVF) services market is segmented based on treatment type, end-user, and region.

Treatment Type:

The conventional IVF segment is expected to dominate the global in vitro fertilization (IVF) services market share

The conventional IVF segment holds a major portion of the global in vitro fertilization (IVF) services market share and is expected to continue to hold a significant portion of the global in vitro fertilization (IVF) services market share during the forecast period.

Conventional IVF (c-IVF) remains one of the most widely practiced assisted reproductive technology (ART) methods globally. However, recent years have seen a significant decline in the number of c-IVF procedures, largely due to the increasing preference for intracytoplasmic sperm injection (ICSI), particularly in cases of non-male-related infertility.

According to the NCBI research study in September 2022, infertility affects approximately 48.5 million couples, translating to around 186 million individuals globally. As a result, assisted reproductive technology (ART) has become the most widely recommended solution for those seeking reproductive assistance. Over the past four decades, significant advancements have been made in this field. According to the International Committee for Monitoring ART (ICMART), more than 8 million babies have been born as a result of ART procedures and other advanced fertility treatments since the birth of the first test-tube baby.

Key advancements in ART include improvements in controlled ovarian hyperstimulation, oocyte retrieval techniques, embryonic culture conditions, and freezing procedures, all of which have significantly enhanced human fertility treatments.

One of the most notable technological innovations in ART is intracytoplasmic sperm injection (ICSI), developed to address the low and unpredictable fertilization rates often encountered with conventional in vitro fertilization (c-IVF), particularly in cases involving poor sperm parameters. However, over the last two decades, there has been a rapid increase in the adoption of ICSI, raising questions about its appropriateness in various clinical situations. These factors have solidified the segment's position in the global in vitro fertilization (IVF) services market.

Geographical Analysis

North America is expected to hold a significant position in the global in vitro fertilization (IVF) services market share

As infertility becomes more prevalent, the demand for IVF services continues to rise. Couples facing difficulties in conceiving are increasingly turning to assisted reproductive technologies as viable options. The growing awareness and acceptance of IVF as a solution contribute significantly to market growth.

Infertility has become a significant health issue, affecting approximately 1 in 8 couples in the United States. This statistic highlights the prevalence of infertility, which can result from various factors including age, lifestyle, and medical conditions. Infertility affects a significant portion of the population, with over 10% of women and around 9% of men experiencing infertility issues in the U.S. This rising prevalence drives demand for IVF services as couples seek effective reproductive solutions.

Continuous improvements in reproductive technologies, including controlled ovarian hyperstimulation and embryo culture techniques, have enhanced the success rates of IVF procedures. Innovations such as intracytoplasmic sperm injection (ICSI) have also contributed to better outcomes, especially in cases of male infertility.

Furthermore, key players in the industry have innovative launches and technological advancements that would drive this in vitro fertilization (IVF) services market growth. For instance, in October 2024, Cook Medical announced the launch of its NestVT vitrification device for In Vitro Fertilization (IVF) in the United States. This innovative device is designed to enhance the safety and efficiency of handling embryos and oocytes during the critical processes of vitrification, cryo-storage, and relocation.

Also, in October 2022, Alife Health launched an innovative AI technology aimed at enhancing In Vitro Fertilization (IVF) treatment outcomes while simultaneously lowering costs. This advancement is part of Alife's mission to modernize and personalize the IVF process through the use of artificial intelligence and data-driven insights.

Thus, the above factors are consolidating the region's position as a dominant force in the global in vitro fertilization (IVF) services market.

Asia Pacific holds the fastest pace in the global in vitro fertilization (IVF) services market and is expected to hold most of the market share.

The rise in infertility cases among both men and women is a significant driver for the IVF market. Factors such as sedentary lifestyles, poor dietary habits, and increased exposure to environmental pollutants contribute to this trend. Common conditions like polycystic ovary syndrome (PCOS) and endometriosis further exacerbate infertility rates, leading many couples to seek assisted reproductive technologies like IVF.

Rapid advancements in IVF technologies have significantly improved success rates and treatment effectiveness. Innovations such as controlled ovarian hyperstimulation, embryo culture techniques, and intracytoplasmic sperm injection (ICSI) have enhanced overall outcomes for IVF procedures, making them more appealing to couples facing infertility. Many governments in the region are introducing supportive policies and funding initiatives aimed at promoting reproductive health services, including IVF. This financial backing helps reduce the costs associated with fertility treatments, making them more accessible to a broader population.

India has experienced a notable surge in In Vitro Fertilization (IVF) services, driven by several interrelated factors. This growth reflects changing societal norms, economic conditions, and increasing awareness surrounding fertility treatments.

Furthermore, key players in the industry introducing innovative technologies and government initiatives that would drive this global in vitro fertilization (IVF) services market growth. For instance, In April 2023, Bengaluru-based DYU Healthcare introduced Smart IVF technology, which leverages artificial intelligence (AI) and advanced algorithms to enhance the in-vitro fertilization (IVF) process. This innovative approach aims to significantly improve the chances of successful pregnancies while providing personalized treatment plans tailored to the unique needs of each patient.

Also, in October 2023, the Telangana government inaugurated the first state-run In Vitro Fertilization (IVF) facility at Gandhi Hospital in Secunderabad, marking a significant advancement in public healthcare services for childless couples. This initiative is particularly noteworthy as it provides IVF services free of cost, which include comprehensive investigations, treatment, hormonal therapy, and follow-up care.

Thus, the above factors are consolidating the region's position as the fastest-growing force in the global in vitro fertilization (IVF) services market.

Competitive Landscape

The major global players in the in vitro fertilization (IVF) services market include Virtus Health, Genea Pty Limited., Aksigen, Shady Grove Fertility, New Hope Fertility Clinic, Boston IVF, Cyprus IVF Centre, EUVITRO S.L.U., Fertility Centers of Illinois, and Houston Fertility Center among others.

Key Developments

In September 2024, MGM Healthcare launched its Varam IVF Centre in Chennai, which aims to provide comprehensive and advanced fertility treatments. This initiative is designed to cater to couples facing infertility challenges by combining specialized medical expertise with state-of-the-art technology and a range of ancillary services, all within one facility.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global in vitro fertilization (IVF) services market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Treatment Type
3.2. Snippet by Connectivity Type
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Incidence of Infertility
- 4.1.2. Restraints
  - 4.1.2.1. High Costs of IVF Procedures
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Treatment Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 6.1.2. Market Attractiveness Index, By Treatment Type
6.2. Conventional IVF *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Intracytoplasmic Sperm Injection (ICSI)
6.4. Mini IVF
6.5. Natural Cycle IVF
6.6. Fresh Cycle IVF
6.7. Frozen Embryo Transfer (FET)
6.8. Others

7. By End-User

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.1.2. Market Attractiveness Index, By End-User
7.2. Fertility Clinics*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hospitals
7.4. Others

8. By Region

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.2.5.1. U.S.
  - 8.2.5.2. Canada
  - 8.2.5.3. Mexico
8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.3.5.1. Germany
  - 8.3.5.2. U.K.
  - 8.3.5.3. France
  - 8.3.5.4. Spain
  - 8.3.5.5. Italy
  - 8.3.5.6. Rest of Europe
8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.4.5.1. Brazil
  - 8.4.5.2. Argentina
  - 8.4.5.3. Rest of South America
8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.5.5.1. China
  - 8.5.5.2. India
  - 8.5.5.3. Japan
  - 8.5.5.4. South Korea
  - 8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Virtus Health*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. Genea Pty Limited.
10.3. Aksigen
10.4. Shady Grove Fertility
10.5. New Hope Fertility Clinic
10.6. Boston IVF
10.7. Cyprus IVF Centre
10.8. EUVITRO S.L.U.
10.9. Fertility Centers of Illinois
10.10. Houston Fertility Center

11. Appendix

11.1. About Us and Services
11.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球体外受精 (IVF) 服务市场 - 2025 - 2032

Global In Vitro Fertilization (IVF) Services Market - 2025 - 2032

市场动态：

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：按治疗类型

第 7 章：最终用户

第 8 章：按地区

第 9 章：竞争格局

第 10 章：公司简介

第 11 章：附录